Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
12/2009
12/01/2009US7625732 Isolated DNA encoding cullin regulators ROC1 and ROC2, isolated proteins encoded by the same, and methods utilizing the same
12/01/2009US7625718 SVCT2 transporters expressed in blood brain barrier cells
12/01/2009US7625573 Immunology active materials; anticancer agents, infections, autoimmune diseases, parasiticides; lipid bilayer with antitumor agent
12/01/2009US7625566 Monoclonal antibody for use as tool in prevention and treatment of viral disease; viricides
12/01/2009US7625562 Generation of cartilage using magnetizable particles
12/01/2009US7625559 Antibodies against Clostridium difficile toxins and uses thereof
12/01/2009US7625557 Transimmunization methods incorporating skin immunologic challenges are described for selectively suppressing immune response of recipients of transplanted tissue or cells or monitoring induced anti-cancer immunity
12/01/2009CA2430607C Self-replicating rna molecule from hepatitis c virus
12/01/2009CA2298956C Genetically engineered cell culture adapted infectious bursal diseases virus (ibdv) mutants
12/01/2009CA2208503C Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders
12/01/2009CA2207906C Production of gamma linolenic acid by a .delta.6-desaturase
12/01/2009CA2107513C Fusion protein for prodrug activation
11/2009
11/26/2009WO2009143476A2 Novel inhibitors of retroviral reverse transcriptase
11/26/2009WO2009143472A2 Method of generating single vl domain antibodies in transgenic animals
11/26/2009WO2009143421A2 Methods for promoting fusion and reprogramming of somatic cells
11/26/2009WO2009143353A1 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
11/26/2009WO2009143241A2 Differentiation of multi-lineage progenitor cells to pancreatic cells
11/26/2009WO2009142888A2 Immortal unipotent porcine picm- 19h and picm- 19b stem cell lines
11/26/2009WO2009142770A2 Compositions and methods for generating musculoskeletal tissue
11/26/2009WO2009142752A1 Method and apparatus for extraction of plant embryos
11/26/2009WO2009142735A2 LUCIFERASE BIOSENSORS FOR cAMP
11/26/2009WO2009142724A2 Novel gpr101 transgenic mice and methods of use thereof
11/26/2009WO2009142454A2 Method for regulating the growth of preadipocytes using sonic vibration
11/26/2009WO2009142271A1 Cancer stem cell having high level of sld5 expression therein
11/26/2009WO2009142221A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody
11/26/2009WO2009141729A2 Anti-tumoral cells
11/26/2009WO2009141664A1 Separation method
11/26/2009WO2009141621A1 Histamine binding protein
11/26/2009WO2009140876A1 Integration methods of enriching and detecting rare cells from biological body fluids samples
11/26/2009WO2009140754A1 An anti-cancer cytotoxic monoclonal antibody
11/26/2009WO2009140724A1 Herg mutants and uses thereof
11/26/2009WO2009116951A3 Microcarriers for stem cell culture
11/26/2009WO2009105612A3 Nucleotide sequences and corresponding polypeptides conferring improved nitrogen use efficiency characteristics in plants
11/26/2009WO2009073618A3 Compositions comprising hdac inhibitors and methods of their use in restoring stem cell function and preventing heart failure
11/26/2009US20090293157 Production of progenitor cereal cells
11/26/2009US20090293154 Isolated Polypeptides, Polynucleotides Encoding Same, Transgenic Plants Expressing Same and Methods of Using Same
11/26/2009US20090293152 Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
11/26/2009US20090293151 Dgat genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in oilseed plants
11/26/2009US20090293149 transformed host cell or plant comprising nucleic acid fragments encoding plant fatty acid modifying enzymes associated with modification of the delta-9 position of fatty acids; producing fatty acid modifying enzymes associated with the modification
11/26/2009US20090293148 Improved Methods Controlling Gene Expression
11/26/2009US20090293146 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield
11/26/2009US20090293145 Acyl-coa-dependent diacylglycerol acyltransferas 1 (dgat1) gene from tropaeolum majus, protein encoded thereby and uses thereof
11/26/2009US20090293144 PLANT NUCLEIC ACIDS ASSOCIATED WITH CELLULAR pH AND USES THEREOF
11/26/2009US20090293143 Corn regulatory sequences for use as tools in enhancing/improving heterologus genic expression in cells; generating stress, herbicide and disease resistant plants
11/26/2009US20090293142 Methods for increasing shoot-to-root ratio, seed production and resistance to diseases
11/26/2009US20090293141 Highly Transformable Elite Doubled Haploid Line-PHWWD
11/26/2009US20090293138 Animal models carrying tumors expressing human prostate cancer-specific antigen and method for analyzing prevention and treatment efficacy of dendritic cells-derived immunotherapeutics
11/26/2009US20090293137 Novel Gene Disruptions, Compositions and Methods Relating Thereto
11/26/2009US20090292311 Biomaterial for Suturing
11/26/2009US20090292112 provide polypeptides inter alia that have been identified as novel proteins with homology to the Mindin family of extracellular matrix proteins (RG1); prostate cancer or benign prostatic hyperplasia, which is alleviated by decreasing the level of RG1 activity
11/26/2009US20090292007 Inhibition of TACE or amphiregulin for the Modulation of EGF Receptor Signal Transactivation
11/26/2009US20090292002 Nucleotide and amino acid sequences relating to respiratory diseases and obesity
11/26/2009US20090291995 bis-(monoethanolamine) salt of 3'-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid; enhanced solubility and bioavailability compared with free acid; agonist of TPO receptor, enhances platelet production; thrombocytopenia
11/26/2009US20090291989 Isothiocyanate compounds, pharmaceutical compositions, and uses thereof
11/26/2009US20090291976 Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors
11/26/2009US20090291956 SALTS OF 2-FLUORO-N-METHYL-4-[7-(QUINOLIN-6-YL-METHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-2-YL]BENZAMIDE AND PROCESSES RELATED TO PREPARING THE SAME
11/26/2009US20090291904 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
11/26/2009US20090291892 SlpA as a tool for recombinant protein and enzyme technology
11/26/2009US20090291890 Factor VII polypeptides that are modified and uses thereof
11/26/2009US20090291888 Modulators of tnf receptor associated factor (traf), their preparation and use
11/26/2009US20090291503 Recombinant Adeno-Associated Virus Production
11/26/2009US20090291501 Rapid Dissolve Media
11/26/2009US20090291500 Production process of an organic/inorganic composite hydrogel, cell culture substrate comprising an organic/inorganic composite hydrogel, and antifogging material comprising a dried organic/inorganic composite hydrogel
11/26/2009US20090291499 Biological tissue-reinforcing material, method of producing the same, use of the same, and method of culturing cells
11/26/2009US20090291498 Biodegradable T-cell activation method
11/26/2009US20090291497 efficient sequence specific gene silencing; gene expression inhibition; increases siRNA efficacy
11/26/2009US20090291496 Neural Stem Cell Isolates from the Dental Papillary Annulus of Developing Teeth
11/26/2009US20090291495 Neural Cell Populations from Primate Pluripotent Stem Cells
11/26/2009US20090291494 Differentiation of Multi-Lineage Progenitor Cells to Pancreatic Cells
11/26/2009US20090291493 Human immunodeficiency virus-neutralizing antibodies with improved breadth and potency
11/26/2009US20090291492 Method for forming organ
11/26/2009US20090291480 Beta-alanine/alpha-ketoglutarate aminotransferase for 3-hydroxypropionic acid production
11/26/2009US20090291470 Chondroitin synthase, method for producing the same and method for producing saccharide chain-extended chondroitin
11/26/2009US20090291462 Detection or Quantification of Aggrecan and its Fragments
11/26/2009US20090291459 Hybridoma capable of producing anti-dectin-1 monoclonal antibody
11/26/2009US20090291455 Cynomolgus gp80 Receptor and Uses
11/26/2009US20090291450 Caterpiller gene family
11/26/2009US20090291441 Polypeptide, nucleic acid molecule encoding it and their uses
11/26/2009US20090291439 Phosphatases involved in the regulation of cardiomyocyte differentiation
11/26/2009US20090291429 Substances causing differentiation
11/26/2009US20090291193 Cereals with Altered Dormancy
11/26/2009US20090291152 Dibenzothiazepine derivatives
11/26/2009US20090291134 Endoxifen methods and compositions in the treatment of psychiatric and neurodegenerative diseases
11/26/2009US20090291129 Formulation of insoluble small molecule therapeutics in lipid-based carriers
11/26/2009US20090291116 Biocompatible and Biodegradable Porous Matrix in Particular Useful for Tissue Reconstruction
11/26/2009US20090291106 Biodegradable block copolymers with modifiable surface
11/26/2009US20090291104 Novel conotoxin framework with a helix-loop-helix fold
11/26/2009US20090291097 IL-17 homologous polypeptides and therapeutic uses thereof
11/26/2009US20090291090 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
11/26/2009US20090291083 Barb4 target, antibody designated barb4, barb4 related antibodies, and methods of making and using same
11/26/2009US20090291081 Dual-specific IL-1A/IL-1b antibodies
11/26/2009US20090291068 Modulation of bio-electrical rhythms via a novel engineering approach
11/26/2009US20090291065 Collection and selection methods of an embryonic-like stem cell population from human adult periodontal follicular tissues
11/26/2009US20090291064 Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines
11/26/2009DE102006011911B4 Isolierung und Identifizierung von mesenchymalen Stammzellen über Frizzled-9 Isolation and identification of mesenchymal stem cells Frizzled-9
11/26/2009CA2725526A1 Anti-tumoral cells
11/26/2009CA2725196A1 Method of differentiating mammalian progenitor cells into insulin producing pancreatic islet cells
11/26/2009CA2725169A1 Method of generating single vl domain antibodies in transgenic animals
11/26/2009CA2724982A1 Histamine binding protein
11/26/2009CA2724839A1 Differentiation of multi-lineage progenitor cells to pancreatic cells
1 ... 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 ... 1827